Egypt Glucose Monitoring Devices Market, By Product (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationEgypt Glucose Monitoring Devices Market, By Product (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 370.6 Million |
| Market Size (2029) | USD 534.78 Million |
| CAGR (2024-2029) | 6.27% |
| Fastest Growing Segment | Hospital |
| Largest Market | Cairo |
Market Overview
Egypt Glucose Monitoring Devices Market
For instance, In January 2024, GlucoTrack is preparing to initiate first-in-human studies for its implantable continuous glucose monitor (CBGM) following the successful completion of preclinical trials. The US-based company, headquartered in New Jersey, has concluded initial studies focusing on device safety and implantation techniques, which were modeled after established cardiovascular implant procedures. The preclinical assessments have paved the way for upcoming human trials, marking a significant step forward in advancing glucose monitoring technology. Trial initiation is anticipated later this year, signaling GlucoTrack's commitment to developing innovative solutions aimed at improving diabetes management through continuous glucose monitoring.
Key Market Drivers
Rising Diabetes Prevalence
For instance, according to the IDF, Egypt ranks ninth globally in diabetes prevalence, with approximately 8,850,400 adult diabetic patients as of early 2020, reflecting a prevalence rate of 15.2%. Egypt is part of the Middle East and North Africa (MENA) region within the IDF. The IDF projects that the number of diabetic patients in the MENA region will double by 2045, reaching 108 million. Alarmingly, 40% to 50% of individuals with diabetes or prediabetes remain undiagnosed, underscoring significant under-recognition of the disease. Egypt is expected to see a substantial increase in diabetic patients by 2035, highlighting the urgent need for enhanced diabetes awareness, screening, and management strategies in the country.
The rising prevalence of diabetes in Egypt underscores the critical need for accessible and effective diabetes management solutions, positioning the glucose monitoring devices market for continued expansion and innovation.
Growing Awareness and Education
Growing awareness and education about diabetes management play a crucial role in shaping the glucose monitoring devices market in Egypt. As awareness increases among both healthcare professionals and the general population, there is a heightened emphasis on the importance of regular blood glucose monitoring for effective diabetes management. Healthcare campaigns, educational programs, and initiatives by healthcare providers and diabetes organizations are pivotal in raising awareness about diabetes, its risk factors, and the benefits of monitoring blood glucose levels. These efforts aim to empower individuals with diabetes to take proactive steps in managing their condition and preventing complications. Patients are increasingly informed about the different types of glucose monitoring devices found at, such as self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring systems (CGMS). They are educated on how these devices work, their benefits, and how to integrate them into their daily routines to maintain better control over their blood sugar levels. The healthcare professionals are becoming more adept at recommending suitable monitoring devices based on individual patient needs and preferences. This personalized approach enhances patient engagement and compliance with monitoring regimens, leading to improved health outcomes.
In Egypt, the growing awareness and education about diabetes management are supported by collaborations between healthcare providers, government agencies, non-governmental organizations (NGOs), and international health organizations. These partnerships facilitate the dissemination of accurate information, implementation of diabetes prevention programs, and promotion of early diagnosis and treatment. The increasing awareness and education about diabetes and the role of glucose monitoring devices contribute significantly to the expanding market in Egypt, fostering greater adoption and utilization of these essential medical technologies.
Key Market Challenges
Economic Constraints
Economic constraints pose significant challenges to the Egypt glucose monitoring devices market, affecting both supply and demand dynamics crucial for the adoption and accessibility of these critical medical tools. Affordability remains a primary issue, particularly for advanced technologies such as continuous glucose monitoring systems (CGMS), which can be prohibitively expensive for many individuals, especially those without adequate health insurance coverage. The overall healthcare expenditure in Egypt, while increasing, may not always align with the growing demand for sophisticated medical devices, limiting their availability in public healthcare facilities and affordability for patients. Currency fluctuations further exacerbate pricing unpredictability for imported devices, impacting budgeting and purchasing decisions. Insurance coverage for glucose monitoring devices varies widely, with gaps in comprehensive coverage potentially placing financial burdens on patients requiring regular monitoring. These economic challenges not only affect market growth but also hinder investment in research and development of new technologies tailored to the local market's needs. Addressing these constraints requires collaborative efforts among healthcare providers, policymakers, insurers, and manufacturers to develop strategies that enhance affordability, improve insurance coverage, and ensure sustainable access to glucose monitoring devices for all individuals managing diabetes in Egypt.
Healthcare Infrastructure
Healthcare infrastructure plays a pivotal role in shaping the Egypt glucose monitoring devices market, influencing both the distribution and utilization of these essential medical technologies. Egypt's healthcare system faces challenges related to disparities between urban and rural areas, where access to healthcare facilities and specialized services can vary significantly. Urban centers generally have better-equipped hospitals and clinics capable of offering advanced diabetes management, including access to a variety of glucose monitoring devices. In contrast, rural areas may lack sufficient infrastructure and resources, limiting the availability and accessibility of these devices for residents. The uneven distribution of healthcare infrastructure impacts the adoption rates of glucose monitoring technologies across the country. Patients in remote or underserved regions may face barriers such as long travel distances to healthcare facilities, limited availability of trained healthcare professionals, and inadequate supply chains for medical devices. These challenges contribute to disparities in diabetes care outcomes and hinder efforts to effectively manage and monitor the disease nationwide.
Efforts to improve healthcare infrastructure are crucial for advancing the glucose monitoring devices market in Egypt. This includes investment in upgrading and expanding healthcare facilities, enhancing medical equipment procurement and maintenance systems, and strengthening healthcare delivery networks. Addressing these infrastructure gaps can help ensure equitable access to glucose monitoring devices, improve diabetes management outcomes, and reduce the overall burden of the disease on individuals and the healthcare system alike.
Key Market Trends
Shift towards Continuous Glucose Monitoring (CGM) Systems
In Egypt, there is a notable shift towards the adoption of continuous glucose monitoring (CGM) systems, reflecting global trends towards more advanced diabetes management solutions. CGM systems offer significant advantages over traditional self-monitoring blood glucose (SMBG) systems by providing continuous real-time data on glucose levels throughout the day and night. This continuous monitoring capability allows for a more comprehensive understanding of glucose fluctuations, which is particularly beneficial for individuals with diabetes requiring intensive management, such as those using insulin pumps or managing unstable blood sugar levels. The adoption of CGM systems in Egypt is driven by several factors. There is increasing awareness among healthcare providers and patients about the clinical benefits of continuous monitoring in improving glycemic control and reducing the risk of diabetes-related complications. This awareness is supported by clinical studies and real-world evidence demonstrating the efficacy of CGM systems in optimizing insulin therapy and enhancing quality of life for individuals with diabetes.
The advancements in CGM technology have led to devices that are more accurate, user-friendly, and less invasive than earlier models. Modern CGM systems are equipped with sensors that require minimal calibration, have longer wear times, and offer wireless data transmission to smartphones or other devices for real-time glucose monitoring and analysis. As healthcare infrastructure in Egypt continues to improve and access to healthcare services expands, there is a growing demand for advanced medical technologies like CGM systems. This trend is supported by collaborations between healthcare providers, technology companies, and diabetes organizations, aiming to enhance the availability and affordability of CGM systems across the country. Therefore, the shift towards CGM systems in the Egypt glucose monitoring devices market underscores a move towards more personalized and effective diabetes management strategies, positioning these advanced technologies as integral components of modern diabetes care in the region.
Integration with Digital Health Platforms
Integration with digital health platforms is becoming increasingly relevant in the Egypt glucose monitoring devices market, revolutionizing how diabetes management is approached and enhancing patient outcomes. Digital health platforms encompass smartphone apps, web portals, and cloud-based systems that connect glucose monitoring devices to digital interfaces, allowing for seamless data collection, analysis, and communication between patients and healthcare providers. In Egypt, the integration of glucose monitoring devices with digital health platforms offers several key advantages. It enables patients to easily track their glucose levels over time, review trends, and gain insights into their diabetes management. This access to real-time data empowers patients to make informed decisions about diet, exercise, medication, and insulin dosing, leading to better glycemic control and reduced risk of complications. The digital platforms facilitate remote monitoring and telehealth consultations, particularly valuable in a country where access to specialized healthcare services may be limited in certain regions. Patients can securely share their glucose data with healthcare providers, who can then provide timely feedback, adjustments to treatment plans, and personalized recommendations without the need for frequent in-person visits.
The integration with digital health platforms promotes patient engagement and adherence to monitoring regimens by offering features such as reminders for testing, medication adherence tracking, and educational resources. These platforms also support caregivers and family members in monitoring the health status of loved ones with diabetes, fostering a collaborative approach to disease management. Therefore, the integration of glucose monitoring devices with digital health platforms in Egypt is transforming diabetes care by improving accessibility, efficiency, and effectiveness of monitoring and management strategies. As these technologies continue to evolve, they hold promise for further enhancing healthcare outcomes and quality of life for individuals living with diabetes in the country.
Segmental Insights
Insights
Based on the Product, self-monitoring blood glucose (SMBG) devices dominated the market over continuous glucose monitoring (CGM) devices, particularly in Egypt. The main reason for this dominance is affordability and accessibility. SMBG devices are generally more affordable for patients and healthcare systems, making them widely accessible across different socioeconomic groups. They are also easier to use and require less frequent calibration compared to CGM systems, which can be advantageous in settings where resources and infrastructure for continuous monitoring may be limited. SMBG devices are well-established in clinical practice and are often covered by health insurance policies, further supporting their widespread use. However, the trend is gradually shifting towards CGM systems as technology advances, costs decrease, and awareness of their benefits grows. CGM systems offer continuous real-time monitoring, which provides more comprehensive data for managing diabetes effectively, thus appealing to patients and healthcare providers seeking tighter glucose control and improved outcomes.
Application Insights
Based on the application, Type 2 diabetes was dominated globally and, in many regions, including Egypt. This dominance is primarily due to its higher prevalence compared to Type 1 diabetes and gestational diabetes. Type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, often associated with lifestyle factors such as obesity, physical inactivity, and unhealthy diet patterns. In Egypt, rapid urbanization, changing dietary habits, and sedentary lifestyles have contributed to the rising prevalence of Type 2 diabetes. Type 2 diabetes is more commonly diagnosed in adults, whereas Type 1 diabetes typically manifests in childhood or adolescence and accounts for a smaller proportion of diabetes cases. Gestational diabetes, which develops during pregnancy, also affects a smaller percentage of women temporarily. Due to its prevalence and associated risk factors, Type 2 diabetes represents a significant public health challenge in Egypt and globally, requiring comprehensive strategies for prevention, early detection, and management to mitigate its impact on individuals and healthcare systems.
Regional Insights
Cairo, as Egypt's capital and largest city, holds a dominant position in the country's glucose monitoring devices market due to several key factors. It boasts a dense population base with higher healthcare infrastructure and accessibility compared to other regions. Cairo is home to leading hospitals, clinics, and healthcare providers equipped to offer advanced diabetes care and a wide range of monitoring devices. The city's concentration of healthcare professionals, research institutions, and market demand contributes significantly to the adoption and distribution of glucose monitoring technologies, making it a central hub for diabetes management innovations in Egypt.
Recent Developments
- In June 2024, Cairo, EgyptRoche has announcedsigning two strategic partnerships aimed at enhancing diabetes care forEgyptian children under 18 over the next five years. These collaborations alignwith Egypt's 2030 vision to achieve universal healthcare access for allcitizens. The first Memorandum of Understanding (MoU) involves RocheDiagnostics, the Egypt Healthcare Authority (EHA), and the Egyptian Authorityfor Unified Procurement, Medical Supply, and Technology Management (UPA). Thesecond agreement is between Roche Diagnostics and the General Authority forHealth Insurance (GHA) under the Ministry of Health and Population, inconjunction with the UPA. These partnerships underscore Roche's commitment toleveraging its expertise and resources in conjunction with Egyptian healthcareauthorities to improve diabetes management and ensure equitable access tohealthcare services across the country.
Key Market Players
- AbbottEgypt
- Agilent Egypt
- Roche Egypt LLC
- FUJIFILM Healthcare Middle East S.A.E.
- Siemens Healthineers Egypt
- Johnson & Johnson
- GE Healthcare Egypt
- Ortho Clinical Diagnostics
- PerkinElmer International C.V.
- LifeScan Egypt
| By Product | By Application | By End User | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy